Answers are grounded in this paper and cite their sources.
We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period.
No takes yet. Share an insight, caveat, or question.
McArthur et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: